Search

Your search keyword '"Desideri, I"' showing total 597 results

Search Constraints

Start Over You searched for: Author "Desideri, I" Remove constraint Author: "Desideri, I"
597 results on '"Desideri, I"'

Search Results

1. REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

4. Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis

6. PSICHE trial (NCT05022914): PSMA guided approach for bIochemical relapse after prostatectomy- a prospective trial

11. Stereotactic body radiation therapy and abiraterone acetate for patients affected by oligometastatic castrate-resistant prostate cancer: Freedom from biochemical, radiological progression free survival and freedom from following treatment approaches within a randomized phase II trial (ARTO – NCT03449719)

12. Palliative Whole Brain Radiotherapy: International State of Practice 2022

13. Long Term Clinical Outcomes of a Cohort of Lung-Only Oligometastatic HNSCC Patients Treated with SBRT

14. Clinical Outcomes and Dosimetric Predictive Factors in Patients Undergoing Reirradiation for Recurrent Meningiomas

15. Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives

19. Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study

22. PD-0576 Stereotactic reirradiation for locally recurrent prostate cancer after definitive radiotherapy

24. PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study

26. PD-0652 Re-irradiation of recurrent intracranial meningiomas: an Italian multicenter retrospective study

27. PO-1459 Stereotactic salvage radiotherapy for prostate red relapse, early analysis from a prospective trial

28. Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis

30. 231P Safety of CDK4/6 inhibitors and concomitant radiation therapy in patients affected by metastatic breast cancer

38. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

39. PO-1363 Detection rate of 68Ga-PSMA PET/CT from a prospective study: PSICHE trial (NCT05022914)

40. OC-0605 Early outcomes of a randomized trial of SBRT and Abiraterore in mCPRC: ARTO trial NCT03449719

41. PO-1299 Charlson Comorbidity Index for patients selection in definitive chemoradiation for anal carcinoma

42. PD-0315 Evaluation of three AI-based CT auto-contouring systems for head&neck, thorax and pelvis

43. PD-0411 Predictive factors of late GU toxicity after Cyberknife re-irradiation for locally recurrent PCa

44. OC-0932 Preoperative radiation therapy in early breast cancer: phase II ROCK trial (NCT03520894)

45. OC-0935 Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis

47. PO-1469 CT-Guided Fiducial Placement for Robotic Stereotactic Body Radiotherapy: Efficacy and Safety

Catalog

Books, media, physical & digital resources